Literature DB >> 22826613

Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Henry Völzke1.   

Abstract

Apart from alcohol, there are other factors that may induce complications, which resemble alcohol-related liver disorders. In particular, obesity has been brought into focus as a risk factor for fatty liver disease. The term "non-alcoholic" fatty liver disease is commonly used to distinguish between obesity-related and alcohol-related hepatic steatosis. This review uses the epidemiological perspective to critically assess whether it is necessary and useful to differentiate between alcoholic and "non-alcoholic" fatty liver disease. The MEDLINE database was searched using the PubMed search engine, and a review of reference lists from original research and review articles was conducted. The concept to distinguish between alcoholic and "non-alcoholic" fatty liver disease is mainly based on specific pathomechanisms. This concept has, however, several limitations including the common overlap between alcohol misuse and obesity-related metabolic disorders and the non-consideration of additional causal factors. Both entities share similar histopathological patterns. Studies demonstrating differences in clinical presentation and outcome are often biased by selection. Risk factor reduction is the main principle of prevention and treatment of both disease forms. In conclusion, alcoholic and "non-alcoholic" fatty liver diseases are one and the same disease caused by different risk factors. A shift from artificial categories to a more general approach to fatty liver disease as a multicausal disorder may optimize preventive strategies and help clinicians more effectively treat patients at the individual level.

Entities:  

Keywords:  Clinical epidemiology; Fatty liver disease; Hepatic steatosis; Risk factors

Mesh:

Year:  2012        PMID: 22826613      PMCID: PMC3400850          DOI: 10.3748/wjg.v18.i27.3492

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  87 in total

1.  Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.

Authors:  Kaushal Madan; Yogesh Batra; S Datta Gupta; Bal Chander; K D Anand Rajan; M S Tewatia; S K Panda; S K Acharya
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  Alcohol consumption and out-patient services utilization by abstainers and drinkers.

Authors:  Sebastian E Baumeister; Anja Schumann; Terry T Nakazono; Dietrich Alte; Nele Friedrich; Ulrich John; Henry Völzke
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

3.  Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Authors:  Phui-Ly Liew; Wei-Jei Lee; Yi-Chih Lee; Hsih-Hsi Wang; Weu Wang; Yang-Chu Lin
Journal:  Obes Surg       Date:  2006-12       Impact factor: 4.129

4.  Regional disparities of hypertension prevalence and management within Germany.

Authors:  Christa Meisinger; Margit Heier; Henry Völzke; Hannelore Löwel; Rolf Mitusch; Hans-Werner Hense; Jan Lüdemann
Journal:  J Hypertens       Date:  2006-02       Impact factor: 4.844

5.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Takayuki Nakagawa; Hiroya Taniguchi; Kota Fujii; Tatsushi Omatsu; Tomoaki Nakajima; Hiroshi Sarui; Makoto Shimazaki; Takahiro Kato; Junichi Okuda; Kazunori Ida
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

Review 6.  Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

Authors:  Karima Begriche; Anissa Igoudjil; Dominique Pessayre; Bernard Fromenty
Journal:  Mitochondrion       Date:  2006-01-05       Impact factor: 4.160

7.  Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.

Authors:  Yasuyo Morita; Takato Ueno; Nozomi Sasaki; Kouichiro Kuhara; Shinichiro Yoshioka; Yukio Tateishi; Eisuke Nagata; Masayoshi Kage; Michio Sata
Journal:  Alcohol Clin Exp Res       Date:  2005-12       Impact factor: 3.455

8.  Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.

Authors:  C Meisinger; H Löwel; M Heier; A Schneider; B Thorand
Journal:  J Intern Med       Date:  2005-12       Impact factor: 8.989

Review 9.  Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors:  Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Circulation       Date:  2006-04-18       Impact factor: 29.690

10.  Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.

Authors:  C Meisinger; A Döring; A Schneider; H Löwel
Journal:  Atherosclerosis       Date:  2006-02-17       Impact factor: 5.162

View more
  22 in total

Review 1.  Dissociating fatty liver and diabetes.

Authors:  Zheng Sun; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2012-10-05       Impact factor: 12.015

Review 2.  Epidemiology of fatty liver: an update.

Authors:  Giorgio Bedogni; Valerio Nobili; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 3.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

4.  Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.

Authors:  Katsutoshi Tokushige; Hideyuki Hyogo; Tomoaki Nakajima; Masafumi Ono; Takumi Kawaguchi; Koichi Honda; Yuichiro Eguchi; Yuichi Nozaki; Miwa Kawanaka; Saiyu Tanaka; Kento Imajo; Yoshio Sumida; Yoshihiro Kamada; Hideki Fujii; Yasuaki Suzuki; Tomomi Kogiso; Yoshiyasu Karino; Kensuke Munekage; Ryoko Kuromatsu; Satoshi Oeda; Mikio Yanase; Kohjiro Mori; Yuji Ogawa; Yuya Seko; Tetsuo Takehara; Yoshito Itoh; Atsushi Nakajima; Kazuyuki Kanemasa; Ken Nishino; Naohiko Masaki; Hirokazu Takahashi; Masataka Seike; Takuji Torimura; Toshiji Saibara; Joji Toyota; Kazuaki Chayama; Etsuko Hashimoto
Journal:  J Gastroenterol       Date:  2015-10-11       Impact factor: 7.527

5.  Hepatic steatosis and steatohepatitis: Are they really two distinct entities?

Authors:  Cory M Fielding; Paul Angulo
Journal:  Curr Hepatol Rep       Date:  2014-06-01

6.  Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019.

Authors:  Aya Sugiyama; Akemi Kurisu; Serge Ouoba; Bunthen E; Ko Ko; Anvarjon Rakhimov; Md Razeen Ashraf Hussain; Tomoyuki Akita; Takayuki Harakawa; Toru Sako; Makoto Koshiyama; Junko Tanaka
Journal:  Liver Int       Date:  2021-09-18       Impact factor: 8.754

7.  Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.

Authors:  Evan J Raff; Donny Kakati; Joseph R Bloomer; Mohamed Shoreibah; Khalid Rasheed; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

8.  Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.

Authors:  Kazuya Okushin; Yu Takahashi; Nobutake Yamamichi; Takeshi Shimamoto; Kenichiro Enooku; Hidetaka Fujinaga; Takeya Tsutsumi; Yoshizumi Shintani; Yoshiki Sakaguchi; Satoshi Ono; Shinya Kodashima; Mitsuhiro Fujishiro; Kyoji Moriya; Hiroshi Yotsuyanagi; Toru Mitsushima; Kazuhiko Koike
Journal:  BMC Gastroenterol       Date:  2015-02-19       Impact factor: 3.067

9.  Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease.

Authors:  Bi-xia Huang; Ming-fan Zhu; Ting Wu; Jing-ya Zhou; Yan Liu; Xiao-lin Chen; Rui-fen Zhou; Li-Jun Wang; Yu-ming Chen; Hui-lian Zhu
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

Review 10.  Essential phospholipids in fatty liver: a scientific update.

Authors:  Karl-Josef Gundermann; Simon Gundermann; Marek Drozdzik; V G Mohan Prasad
Journal:  Clin Exp Gastroenterol       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.